Research advances in diagnosis and treatment of liver failure in 2016
10.3760/cma.j.issn.1007-3418.2017.02.003
- VernacularTitle: 2016年肝衰竭诊治进展
- Author:
Fangji YANG
1
;
Liang PENG
1
;
Yueying LIU
2
;
Zhiliang GAO
1
;
Tao HAN
3
;
Jianrong HUANG
2
Author Information
1. Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
2. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou 310003, China
3. Department of Hepatology, Tianjin Third Central Hospital, Tianjin 300170, China
- Publication Type:Journal Article
- Keywords:
Hepatitis B virus;
Liver failure;
Liver, artificial;
Diagnosis;
Therapeutics;
Infection;
Fungi
- From:
Chinese Journal of Hepatology
2017;25(2):94-99
- CountryChina
- Language:Chinese
-
Abstract:
Liver failure has various clinical types, a complex pathogenesis, and rapid disease progression, as well as a high mortality rate. Liver failure caused by hepatitis B virus infection is the most common type in China with severe conditions, various complications, and a mortality rate as high as 40%-90%. Invasive fungal disease secondary to acute-on-chronic liver failure can affect patients’ prognosis and increase mortality rate. This article introduces the research advances in hepatitis B-related liver failure, artificial liver, and invasive fungal disease secondary to acute-on-chronic liver failure in 2016.
